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of spectral microscopy. Extensive theoretical consider-
ations provided the basis for the success of the spectral 
karyotyping (SKY) technology in daily practice of routine 
karyotyping and in research (Schrock et al., 1996; Garini 
et al., 1999). The probes are labeled by degenerate oligo-
nucleotide primed PCR using three fluorochromes and 
two haptens. Each probe is differentially labeled with one, 
two, three or four fluorescent dyes, resulting in a unique 
spectral signature for every chromosome. After in situ hy-
bridisation and immunodetection, a spectral image is ac-
quired using a conventional fluorescence light microscope 
equipped with a custom-designed triple-bandpass filter 
and the SpectraCube  , which is able to retrieve spectral 
 Abstract.  Spectral karyotyping (SKY) is a widely used 
methodology to identify genetic aberrations. Multicolor 
fluorescence in situ hybridization using chromosome paint-
ing probes in individual colors for all metaphase chromo-
somes at once is combined with a unique spectral measure-
ment and analysis system to automatically classify normal 
and aberrant chromosomes. Based on countless studies and 
investigations in many laboratories worldwide, numerous 
new chromosome translocations and other aberrations have 
been identified in clinical and tumor cytogenetics. Thus, 
gene identification studies have been facilitated resulting in 
the dissection of tumor development and progression. For 
example, different translocation partners of the  TEL/ETV6 
transcription factor that is specially required for hemato-
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poiesis within the bone marrow were identified. Also, the 
correct classification of complex karyotypes of solid tumors 
supports the prognostication of cancer patients. Important 
accomplishments for patients with genetic diseases, leuke-
mias and lymphomas, mesenchymal tumors and solid can-
cers are summarized and exemplified. Furthermore, stud-
ies of disease mechanisms such as centromeric DNA 
breakage, DNA double strand break repair, telomere short-
ening and radiation-induced neoplastic transformation 
have been accompanied by SKY analyses. Besides the hy-
bridization of human chromosomes, mouse karyotyping 
has also contributed to the comprehensive characterization 
of mouse models of human disease and for gene therapy 
studies.  Copyright © 2006 S. Karger AG, Basel 
 Spectral karyotyping was published in 1996 (Schrock et 
al., 1996) and is a well established fluorescence in situ hy-
bridisation (FISH) technique that refers to the molecular 
cytogenetic analysis of metaphase preparations by means 
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information for every pixel in a digital CCD image. The 
24-colour display and chromosome classification are based 
on the unique emission spectra of the chromosomes. To-
gether with chromosome banding information from an in-
verted DAPI or a G-banded metaphase, a comprehensive 
overview and detailed information of chromosomal aber-
rations is obtained using the automated Software SKY-
View  and HiSKY  (Applied Spectral Imaging, Inc., 
Migdal Ha’Emek, Israel). Results for patient diagnostics 
and prognostication should always be confirmed using
locus-specific probes.
 To catalog data on chromosomal aberrations in cancer 
derived from emerging molecular cytogenetic techniques 
and to integrate these data with genome maps, Knutsen et 
al. (2005) have established two resources, the NCI and NCBI 
SKY/M-FISH and CGH Database and the Cancer Chromo-
somes database. These datasets can be searched seamlessly 
by use of the Entrez search and retrieval system. 
 Reviews of the advances by using the SKY technology 
have been published periodically (Popescu, 2000; Schrock 
and Padilla-Nash, 2000; Bayani and Squire, 2001, 2002; Xu 
and Chen, 2003). 
 SKY has also been applied in conjunction with several 
other methods. Identifying genes that flank chromosomal 
reconfigurations is an important task in cancer cytogenet-
ics. Tonon et al. (2000) developed a novel approach to iden-
tify gross chromosomal aberrations as well as to detect the 
involvement of specific loci in these rearrangements in a 
single step. This method will be particularly useful for the 
analysis of complex karyotypes and for testing hypotheses 
arising from cancer gene expression studies (Tonon et al., 
2000). Technically also supportive of determining chromo-
somal aberrations is the combination of SKY analysis, mi-
crodissection of distinct aberrant chromosome and reverse 
painting (Weimer et al., 2001). Combined protocols involv-
ing SKY, FISH and immunostaining allow for the tracking 
of key genes or targeted chromosome regions while moni-
toring changes throughout the whole genome. This ap-
proach facilitates the simultaneous monitoring of protein 
complexes and DNA loci within the genome (Ye et al., 
2001).
 The resolution limit of SKY to detect interchromosomal 
changes was originally determined to be in the range of 1–
2 Mb when analyzing metaphases obtained from lympho-
cytes or amniocytes (Schrock et al., 1996). This finding was 
independently confirmed (Fan et al., 2001). Limitations of 
chromosome classification by SKY and M-FISH were deter-
mined by Lee et al. (2001). Depending on the length of the 
chromosomes, false insertions may be interpreted at the in-
terface of translocated segments. Also, small insertions may 
be misinterpreted or completely missed. Difficult to iden-
tify are coamplifications involving material from nonho-
mologous chromosomes. 
 Nevertheless, the power of the technology in experi-
enced hands cannot be overrated. The following chapters 
will illustrate the different applications and demonstrate 
the usefulness of the SKY analysis.
 Applications of chromosome analysis using SKY in 
clinical genetics 
 The identification of chromosome aberrations or the de-
scription of a normal karyotype is important for patients 
afflicted with genetic diseases. A correct diagnosis is very 
helpful for the further concerted actions of the patients, the 
family members, the medical doctors and genetic counsel-
lors. The SKY technology has widely been used for prenatal 
and postnatal diagnostics, in particular for delineating bal-
anced and unbalanced translocations and for determining 
the chromosomal origin of marker chromosomes. Geno-
type-phenotype correlations of patients who either share 
similar phenotypes or whose chromosome aberrations in-
volve overlapping DNA sequences support the strategies of 
disease gene identification. The following examples of pre- 
and postnatal cases illustrate the power of the SKY method-
ology contributing to a precise diagnosis in patients. 
 A hidden Down syndrome was suspected because of 
 abnormal ultrasound findings in two fetuses at 18 and 
30 weeks of gestation. In the first case, the origin of addi-
tional material on chromosome 1pter was determined by 
SKY as being derived from chromosome 21 and the karyo-
type was designated as 46,XY,der(1)t(1; 21)(p36.3;q22.1).ish 
der(1)(WCP21+, LSI21+, 1pTEL–, 21q TEL+) de novo (Hsieh 
et al., 2004). In the second case, an unbalanced situation was 
revealed as 46,XY,der(21)t(20;  21)(q13.2;q22.13 or 22.2)mat, 
with the mother and maternal grandmother being balanced 
translocation carriers (Leppig et al., 2000). Autism and de-
velopmental delay in a patient were found to be related to a 
de novo translocation t(2;  8)(q32;q21.2) accompanied by a 
cryptic deletion at the breakpoint on chromosome 2 (Borg 
et al., 2002). An infant born with total anomalous pulmo-
nary venous return (TAPVR) showed an extra ring chromo-
some resulting from a duplication involving the short arm 
of chromosome 12 (Harris et al., 2004). A very rare de novo 
Y-autosome translocation consisting of chromosomal re-
gions on chromosomes 5 and Y was found in association 
with a partial duplication of Yq in a male newborn patient 
with Cri-du-chat syndrome (karyotype 46,XY.ish der(5)t(Y;
5)(q11.2;p15.3)(SKY+,Xq/YqTEL+,5pTEL–)) (Chen et al., 
2005). Other studies were performed with comparable re-
sults (Schrock et al., 1997; Phelan et al., 1998; Peschka et al., 
1999; Heng et al., 2003). Surprisingly, a complex chromo-
somal rearrangement consisting of 16 fragments was re-
ported in a boy with moderate mental retardation and very 
short stature. The karyotypes of his parents and his brother 
were normal (Houge et al., 2003). 
 A combination of subtelomeric FISH and SKY analysis 
was performed in order to study 50 children with idiopath-
ic MR or developmental delay and normal GTG-banded 
karyotypes (Clarkson et al., 2002). Three rearrangements 
were detected by subtelomeric FISH: a derivative chromo-
some 5 from a maternal t(5;  21), a recombinant chromosome 
11 from a paternal pericentric inversion, and a partial dele-
tion on the long arm of chromosome 2 that was present in 
the mother as well. The derivative chromosome 5 was also 
detected by SKY, whereas the other two aberrations were too 
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small to be seen. In addition, SKY analysis revealed a low-
level mosaicism for trisomy 9 in one patient. Unbalanced 
subtelomeric translocations were also confirmed by SKY 
subsequent to subtelomere FISH in three out of four patients 
(Anderlid et al., 2002). 
 Extra structurally abnormal chromosomes (ESACs) and 
cryptic rearrangements are often associated with mental re-
tardation and phenotypic abnormalities. SKY analysis per-
mitted the classification of marker chromosomes and chro-
mosome rearrangements and the results were confirmed by 
using locus/gene-specific probes with FISH analysis (Had-
dad et al., 1998; Huang et al., 1998; Ning et al., 1999; Yaron 
et al., 2003; Guanciali-Franchi et al., 2004; Tabet et al., 
2004). However, in two cases of small bisatellited chromo-
somes, SKY was noncontributory (Yaron et al., 2003). Nev-
ertheless, often one can gain suggestions from which chro-
mosomes ESACs might be derived by using the SKY analy-
sis. Thus, a small series of subsequent FISH experiments 
will elucidate the exact chromosomal origin. 
 Mosaic karyotypes with 1–6 supernumerary marker 
chromosomes were identified in a 7-month-old boy with 
developmental delay and congenital abnormalities and a 58-
year-old man with mental retardation, impaired speech, 
and dysmorphic features. The majority of the markers ap-
peared like rings and were rather small showing only min-
ute amounts of euchromatin. SKY analysis followed by 
chromosome painting was performed to determine the ori-
gin of the marker chromosomes. Based on their own obser-
vations and a review of the literature the authors suggested 
that the nature and extent of the euchromatin content of the 
multiple markers appeared to determine the phenotype of 
the patients (Reddy et al., 2003). 
 Fibroblast cultures from two patients with Werner syn-
drome (WS) were analyzed by SKY detecting multiple, 
pseudodiploid clones, mostly marked by random balanced 
reciprocal translocations. The study confirmed the exis-
tence of variegated translocation mosaicism as the cytoge-
netic hallmark of WS fibroblast cultures. It was suggested 
that tetraploidization in combination with certain chromo-
some rearrangements and selective chromosome dosage 
may overcome the severely limited in vitro lifespan of WS 
fibroblasts (Melcher et al., 2000).
 Spontaneous abortions may be caused by unbalanced 
translocations as a result of a balanced situation in one of 
the parents. Prenatal diagnostics using SKY analysis al-
lowed for the identification of parental complex transloca-
tion carriers and of chromosome rearrangements in the fe-
tuses (Tanemura et al., 2001). For instance, the karyotype 
46,XX,t(8;11;12)(8qter ] 8p10::12p10 ] 12pter;11pter ] 11q
14::8p10 ] 8pter; 12qter ] 12p10::11q14 ] 11qter) was identi-
fied in a woman who experienced five abortions (Kotzot et 
al., 2001). 
 Karyotyping meiotic metaphase chromosomes from hu-
man oocytes and polar bodies has been crucial for in vitro 
fertilization (IVF) attempts. Cytogenetic studies on sponta-
neous abortions have clearly shown that chromosomal ab-
normalities constitute the major contributing factor to hu-
man embryo wastage and low rates of pregnancy following 
IVF in women of advanced maternal age. Marquez et al. 
(1998) obtained a hybridization efficiency of 95.2% with 
SKY analysis on human MII oocytes, a much higher rate 
than the previous frequency of 35.4% accomplished using 
banding techniques and a little higher than the 81.3% 
achieved by FISH. Thus, SKY was judged as the most ap-
propriate method for the cytogenetic analysis of female 
gametes, since ideally all the chromosomes are simultane-
ously and distinctively labeled and identified (Pellestor et 
al., 2005). Furthermore, the observation of balanced chro-
matid predivision in fresh, non-inseminated metaphase II 
oocytes suggested that chromatid predivisions contribute to 
the occurrence of aneuploidy in human oocytes (Sandalinas 
et al., 2002). 
 Recently, a great improvement has been achieved for the 
characterization of chromosome aberrations by the combi-
nation of high resolution Array CGH and SKY analyses. A 
healthy father and his disabled son both showed an addi-
tional band on the long arm of chromosome 16 observed by 
conventional G-banding. SKY analysis revealed a balanced 
t(4;  16) in the father and an unbalanced der(16)t(4;  16) in the 
son. Translocation breakpoints and the size of the deletion 
and the translocated fragments were determined by Array 
CGH analysis using a custom-made 6.000 BAC array fol-
lowed by FISH experiments with locus-specific probes 
( Fig. 1 , Matthaei et al., 2005). 
 Molecular cytogenetic diagnostics and research in 
leukemias and lymphomas 
 SKY and FISH analysis of leukemias and lymphomas 
have been well accepted within the scientific community 
and also in diagnostic settings. In tumor cytogenetic labo-
ratories G-banding and FISH analyses are being routinely 
applied side-by-side to determine chromosomal changes 
and tumor heterogeneity by studying metaphase chromo-
somes and uncultured interphase nuclei. In case of normal 
karyotypes or complex aberrations, investigations using 
SKY or M-FISH are performed in addition to resolve chro-
mosome rearrangements. The identification of new trans-
locations and cryptic changes initializes gene identification 
studies followed by the disclosure of signalling pathways 
that are involved in tumorigenesis.
 Chromosome rearrangements, misclassified or unde-
tected by standard cytogenetic techniques, were identified 
in numerous AML and ALL patients (Veldman et al., 1997; 
Calabrese et al., 2000b, 2002; Kelly et al., 2002; Mrozek et 
al., 2002). For instance, SKY analysis detected chromosom-
al aberrations in 7% of the analyzed AML samples with nor-
mal karyotypes, e.g. a cryptic 11q23 translocation and a mi-
nor monosomy 7 clone (Zhang et al., 2000; Hilgenfeld et al., 
2001). Mohr et al. (2000) found an apparently new translo-
cation t(7;  14) in two out of 39 AML and MDS patients. In 
the AML-M2 subgroup more than 70 chromosomal aberra-
tions were identified in 37 patients, among them 17 new and 
16 redefined unbalanced translocations. Two reciprocal 
translocations t(X;3)(q24;p21) and t(11;  19)(q23;p13.1) were 
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found, which were missed by G-banding analysis (Hilgen-
feld et al., 2001). A child, diagnosed with AML-M2 and 
characterized by the translocation t(8;  21)(q22;q22)  (AML1-
RUNX1T1) , developed a therapy-related myelodysplastic 
syndrome (tMDS). A new chromosomal translocation t(2; 
 8)(p23;p11.2) was detected by SKY analysis and the  MYST3 
 gene on chromosome band 8p11 was found to be rearranged 
using FISH.  MYST3,  fused to an unidentified partner gene 
at chromosome band 2p23, may have caused an alteration 
in histone acetylation, resulting in the development of tMDS 
in this patient (Imamura et al., 2003). A new myeloid cell 
line, designated YSK-21, also carrying the balanced translo-
cation t(8;  21), revealed in addition an unbalanced der(1)t(1; 
 17)(p36;q21). This unbalanced translocation was accompa-
nied by a deletion of one allele and partial demethylation of 
the second allele of the tumor suppressor gene  TP73 (1p36) 
and by a point mutation in one copy of the  TP53 gene on 
17q21. Infant AML with X chromosome disruption and 
 MLL -gene translocation was reported in two cases, one with 
a translocation t(X;11) and one with a complex transloca-
tion t(X;3;  11). The identification of  SEPT6 and the  SEPTIN 
family members  SEPT5 and  SEPT9 as partner genes of the 
 MLL gene suggested a common pathway to leukaemogen-
esis (Slater et al., 2002). A young girl was found to be af-
flicted with aggressive acute monoblastic leukemia (AML) 
(M5b) with skin, lymph node, and bone marrow involve-
ment. Cytogenetic analysis revealed three clones with dif-
ferent secondary chromosomal changes. Using SKY tech-
nology Stark et al. (2002) detected that all three clones orig-
inated from a common clone that harbored the hidden 
primary and very poor prognostic translocation t(10; 11)
(p13;q23) or its derivatives, suggesting clonal evolution of 
the disease. 
 The translocation t(1; 19)(q21 ] q23;p13.3) involving the 
long arm of chromosome 1 and the short arm of chromo-
some 19 is usually associated with acute lymphoblastic leu-
kemia. Tchinda et al. (2002) found a new translocation with 
one virtually identical breakpoint on chromosome band 
19p13 and the other breakpoint on chromosome band 1p13 
in two cases of myeloid neoplasms, a 13-month-old child 
with the diagnosis of acute monocytic leukemia (AML 
M5a), and a bone marrow sample of a 21-year-old woman 
with MDS, subtype refractory anemia with ringed sidero-
blasts (RARS) probably associated with a Fanconi anemia 
(FA).
 Multiple chromosome rearrangements (MCRs) are seen 
in 5–10% of newly diagnosed patients with acute myeloid 
leukemia (AML) and 15–30% of patients with myelodys-
plastic syndromes (MDS), in particular in patients of old 
age, with previous exposure to radio- and/or chemotherapy 
and a short survival time (Lindvall et al., 2001). Some MCRs 
detected in AML were similar to MCRs described in MDS 
and often resulted in partial deletions of chromosomes 5, 7 
and 17 and gains of chromosome 8. The chromosomal 
changes were complemented by gene expression data show-
ing that the differentially expressed genes were located on 
chromosome arms 5q and 7q (Lindvall et al., 2004). 
 Fig. 1. Combined SKY, FISH and Array CGH analyses on meta-
phase chromosomes of the father and the propositus. More detailed 
information as well as the clinical phenotype can be found in the paper 
by Matthaei et al. (2005). ( A ) SKY revealed an reciprocal insertion (ar-
rows) between chromosomes 4 and 16 in the father, which was con-
firmed by chromosomal painting ( B ). ( C ) Example of a split hybridiza-
tion signal indicating that BAC RP11-52k8 (red) spans the telomeric 
breakpoint of the der(4) in chromosome band 4q28.1 (arrow) and thus 
also shows a hybridization signal (arrow) on the der(16)ins(4;  16)
(q26q28.1;q12.1q12.2). ( D ) Array-CGH analysis using DNA from the 
patient showing the unbalanced insertion der(16)ins(4;  16)(q26q28.1;
q12.1q12.2) on a chip with 6000 BACs indicating a gain of the chromo-
somal region 4q26 ] q28.1 and a loss of 16q12.1 ] q12.2 (arrows). Re-
printed from Matthaei et al. (2005) with permission from Elsevier. 
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 Erythroid leukemia (ERL or AML-M6) is an uncommon 
subtype of acute myeloid leukemia awaiting further de-
tailed characterization. Cigudosa et al. (2003) analyzed a 
homogeneous group of de novo AML-M6 patients and leu-
kemia cell lines with an erythroid phenotype. Hypodiploi-
dy, monosomies of chromosomes 7 or 18 and deletions of 
chromosome arm 5q were repeatedly found. Interestingly, 
 MLL gene rearrangements were detected in 20% of the cas-
es. Two novel, cryptic and recurrent translocations were de-
scribed as translocation t(11;  19)(p11.2;q13.1) and transloca-
tion t(12;  21)(p11.2;q11.2). Thus, primary samples and cell 
lines shared three common breakpoints at 19q13.1, 20q11.2, 
and 21q11.2. These data may contribute to the identification 
of genes involved in erythroleukemogenesis (Cigudosa et 
al., 2003). 
 At the present time tumor suppressor genes are being 
hunted for on the long arm of chromosome 5. Knutsen et al. 
(2003) established two t-AML cell lines, which carry partial 
deletions on the long arm of chromosome 5 and may prove 
useful in the study of the mechanisms leading to the devel-
opment of t-AML. 
 Gene amplifications have rarely been found in leukemias 
and lymphomas. A cell line with megakaryoblastic features 
that contains an amplification of the normal germline con-
figuration of the  MLL gene was established and analyzed by 
Allen et al. (1998) from an AML patient. The first evidence 
for the amplification of the  RUNX1  gene in MDS cases was 
provided by Kakazu et al. (1999). SKY analysis revealed that 
double minute chromosomes (DMINs) in AML and MDS 
patients were derived from chromosomes 8, 11 and 19. The 
exact origins of the amplified sequences were finally deter-
mined using FISH with BAC DNA probes (Sait et al., 
2002). 
 The power of the SKY technique was again demonstrat-
ed when stratified cohorts of childhood B-lineage acute 
lymphoblastic leukemias (B-ALLs) with more than 150 pa-
tients were re-evaluated subsequently to chromosome band-
ing (Elghezal et al., 2001; Mathew et al., 2001; Nordgren et 
al., 2002). Twelve of 70 ALL patients showed prognostically 
unfavourable chromosomal aberrations that were missed 
before (Nordgren et al., 2002). Three novel translocations: 
a der(X)t(X;5)(p11.4;q31), a der(21)t(X;21)(p11.4;p11.2) and 
a t(X;9)(p11.4;p13) were found in four of ten patients with 
previously seen marker and derivative chromosomes 
(Mathew et al., 2001). Elghezal et al. (2001) found that alto-
gether 83 chromosome aberrations went undetected or were 
not characterized using chromosome banding in two-thirds 
of 51 cases. A rearrangement of the  PAX5  gene was identi-
fied in a case of pediatric ALL with the translocation t(2; 
 9)(p11.2;p13) as well as other non-recurrent translocations 
(Lu et al., 2002). Tumor cells from ALL patients with appar-
ently normal karyotypes harboured genetic aberrations that 
are detectable using interphase FISH and SKY (Nordgren et 
al., 2001b). Also Mathew et al. (2001) identified three cryp-
tic translocations: a t(7;  8)(q34 ] 35;q24.1), a t(13;  17)(q22;
q21) and a der(19)t(17;  19)(q22;p13) in two of 20 pediatric 
ALL patients (10%) with normal karyotypes. In contrast, 
the translocation t(12;  21) was not always picked up by SKY, 
depending on the lengths of the analyzed chromosomes. A 
non-random pattern of chromosomal changes was identi-
fied in 15 high hyperdiploid ( 1 51 chromosomes) childhood 
ALLs, which typically display a poor chromosome mor-
phology. The numerical changes, with chromosomes X, 21, 
14, 17, 6, 18, 4, and 10 being most frequently gained, some 
of which, i.e. +4 and +10, have been suggested to be prog-
nostically important, were partly misinterpreted in 12 of the 
15 ALL patients using G-banding. Five rearrangements 
[der(1)t(1;  14)(q32;q21), der(2)t(2;  8)(q36;?), der(3)t(2;  3)
(q21;?), der(8)t(8;  14)(?;?), and t(9;  21)(q12;q22)] had previ-
ously not been reported in ALL (Nordgren et al., 2001a).
 Mature B-cell acute lymphoblastic leukemia (ALL) is 
typically associated with the FAB-L3 morphology and a re-
arrangement of the  MYC gene. In contrast, infantile B-cell 
ALL is generally characterized by a rearrangement of the 
 MLL gene, an immature pro-B-cell phenotype, and CD10 
negativity. Two unusual cases of infantile B-ALL with non-
L3 morphology and expressing a mature B-cell phenotype 
were described by Tsao et al. (2004). These patients may 
represent a distinct subset showing the translocation  t(9;  11) 
with an MLL gene rearrangement but without rearrange-
ments of the  MYC gene. The tumor cells of a patient with 
refractory anaemia with excess of blasts (RAEB) showed a 
complex karyotype with multiple copies of the  MLL gene 
resulting from an unbalanced translocation der(20)t(11;  20) 
and three unbalanced derivative chromosomes der(11). The 
patient died 6 months after diagnosis, thus indicating the 
severe prognosis of  MLL gene amplifications (Calabrese et 
al., 2003).
 TEL / ETV6  was the first transcription factor identified 
that is specifically required for hematopoiesis within the 
bone marrow. Odero et al. (2001) identified six new  TEL/
ETV6  translocation  partners in chromosome bands 1p36, 
4q22, 6p21, 6q25, 12q24, and 17q12. Lu et al. (2002) found a 
translocation t(12;  14)(p13;q32) and confirmed the fusion of 
 TEL/ETV6  with  IGH for the first time in a pediatric ALL 
patient. Three other novel  TEL/ETV6 partner breakpoints 
were described by Nordgren et al. (2002) on chromosome 
bands 1p32, 1q41, 8q24 and 21p12.
 Complex chromosome aberrations often occur in chron-
ic myeloid leukaemia (CML) patients undergoing a blastic 
crisis. A patient with a Ph-positive CML underwent alloge-
neic peripheral blood stem cell transplantation. Several 
months later the disease progressed towards a blastic crisis 
and the karyotype was determined to be complex with a 
t(20;  21)(q11;q22) involving the  RUNX1 gene and transloca-
tions and insertions of chromosomes 8 and 1 in addition to 
the translocation t(9;  22) (Calabrese et al., 2000a). Under-
standing the complex aberrations occurring in 5–10% of the 
CML patients will facilitate the interpretation of complex 
FISH signal patterns in interphase nuclei during follow-up 
investigations. We have identified a complex Ph transloca-
tion and additional aberrations in a CML patient using SKY. 
Chromosomes 6, 9, 11, 13, and 22 contributed to the com-
plex translocations whereas chromosome 7 was lost and 
chromosomes 3 and 12 were involved in a reciprocal trans-
location ( Fig. 2 ). 
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 Fig. 2. Sequential G-banding and SKY analy-
sis of a tumor cell obtained from a CML patient. 
( A ) Chromosomes 3, 6, 7, 11, 12, 13 and 22 showed 
abnormal banding patterns or were lost, but chro-
mosome 9 appeared to be normal. ( B ,  C ) SKY re-
vealed the loss of chromosome 7, the reciprocal 
translocation t(3;  12)(q27;p13) and the complex 
variant Ph translocation t(6;  11;  9;22;  13)(q25;q25;
q34;q11;q14). The patient was analyzed in co-
operation with Prof. Dr. med. Bernd Dörken, 
 Cha rité – Universitätsmedizin Berlin, Campus 
Virchow – Klinikum, Medizinische Klinik mit 
 Schwerpunkt Hämatologie und Onkologie, Ber-
lin, Germany. 
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 The  NPM-ALK fusion gene as a result of the chromo-
some translocation t(2;  5)(p23;q35) is usually found in lym-
phomas with a T cell or null phenotype. However, Adam et 
al. (2003) described the same fusion gene with respect to a 
complex chromosome translocation of a plasmablastic lym-
phoma of unequivocally proven B-cell lineage (Adam et al., 
2003). 
 The translocation t(14;  18)(q32;q21), recombining the 
immunoglobulin heavy chain  (IGH) gene on chromosome 
14 with the B-cell leukemia/lymphoma 2  (BCL2) gene on 
chromosome 18, is a typical feature of follicular lympho-
mas (FLs). The progression of FL may be associated with 
multiple secondary IGH translocations and insertions
(Nomura et al., 2005). Diffuse large B-cell lymphoma
(DLBCL), a histologically well-defined subset of non-
Hodgkin lymphomas, revealed new recurring break-
points, translocations, and regions of gains and losses, 
namely, gain of chromosomal regions 2p22 ] p13, 2q21, 
3q27 ] q29, 9p24 ] p11, 13q22 ] q34, 18q21, and 19q11 ] q13 
and loss of chromosomal bands 6q11 ] q13 and 18p11.
SKY analysis identified three sites (2q31, 3q27, 7q22) sig-
nificantly associated with advanced-stage disease or poor 
treatment response (Nanjangud et al., 2002). Also, a new 
translocation partner for the 14q32 translocation was
found on 22q13 in a non-Hodgkin’s lymphoma with
complex chromosomal abnormalities (Kakazu et al., 
2000). 
 Cell lines, derived from sporadic Burkitt Lymphoma 
(BL) and negative for Epstein-Barr virus (EBV), were found 
to contain the translocation t(8;  14)(q24;q32) involving the 
 c-myc gene and the IGH locus. Additionally, the complex 
translocations t(7;  8;14)(q11.2;q24;q32) and t(8;  14;  18)(q24;
q32;q23) were described, which resulted in transposition of 
 MYC sequences in a new genomic configuration. The tu-
morigenicity of the cell lines was tested by injecting cells 
intraperitoneally into SCID mice. One cell line, which con-
tained a partial duplication of the long arm of chromosome 
1, was highly tumorigenic suggesting that this region har-
bors gene(s) associated with tumor cell invasiveness (Zi-
monjic et al., 2001). 
 Blastic natural killer cell leukaemia/lymphoma (bNKL/
L) has been considered to constitute a distinct entity with 
complex cytogenetic abnormalities. Kuroda et al. (2000) de-
tected a translocation t(4;  14)(q12;q11.2) in a patient afflict-
ed with aggressive NK cell leukemia/lymphoma. The chro-
mosomal band 14q11.2 is a recurring breakpoint in T-cell 
non-Hodgkin lymphoma, and is also the locus of the   chain 
of the T-cell receptor. Jyoko et al. (2002) described the 
karyotype of a patient as 44,X,–Y,–8,der(10)t(8;  10)(q11;
p11),der(11)t(Y;11)(p11;q13),–13,der(16)t(11;16)(q13;p13),
i(17)(q10),+20,der(20)t(4;  20(?;p11)x2. The unbalanced 
translocations involving the breakpoints at 10p11 and
11q13 were also found in two previous cases. Additional pa-
tients should be studied to facilitate the elucidation of the 
pathogenesis of NKL/L. 
 Malignant non-Hodgkin lymphoma (NHL) cell lines de-
rived at the Ontario Cancer Institute (OCI), Toronto, re-
vealed 87 breakpoints, which clustered at chromosome 
bands 1q21, 7p15, 8p11, 13q21, 13q32, 14q32, 17q11, and 
18q21. The SKY analysis led to the identification of 60 trans-
locations, including five that were recurring, translocations 
t(8;  14)(q24;q32), t(14;  18)(q32;q21), t(4;  7)(p12;q22), t(11;  18)
(q22;q21), and t(3;  18)(q21;p11). Furthermore, the sources of 
all marker chromosomes were determined and 10 chromo-
somes that were classified as normal by G-banding were 
found to be rearranged (Mehra et al., 2002). For pathoge-
netic investigations of how secondary non-Hodgkin lym-
phomas may occur in patients treated for Hodgkin lympho-
ma (HL), a cell line derived from a patient afflicted with a 
DLBCL with relapsing HL was thoroughly investigated us-
ing G-banding, CGH and SKY analysis (Amini et al., 2002). 
Besides a mutation of the  TP53 gene, the cell line carried a 
complex karyotype including regional amplifications of 
chromosome bands 1q12 ] q23, 3q27, 11q21 ] q23 and 
18q21. The authors hypothesized that NHL occurred after 
treatment for HL either as a chemotherapy-induced tumor 
or as a result of the HL progression. 
 The first complete Hodgkin disease (HD) karyotype ob-
tained from cell lines was published by MacLeod et al. 
(2000). The authors reported for the first time a genomic 
rDNA rearrangement in tumor cells. They also identified 
multiple ‘jumping translocations’ (JT). These data suggest-
ed that tumorigenic rearrangements may be facilitated in 
HD by ‘hitchhiking’ along with mobile DNA repeat se-
quences resulting in gene rearrangements at chromosome 
arm 9p (MacLeod et al., 2000).  
 Obtaining karyotypic information on multiple myeloma 
(MM) cells is difficult due to low mitotic activity of the ma-
lignant plasma cells. Rao et al. (1998) identified several nov-
el recurring sites of breakage on chromosome bands 3q27, 
17q24 ] q25, and 20q11. New recurrent translocations in-
cluded t(12;  14)(q24;q32) and t(14;  20)(q32;q11) (Rao et al., 
1998), t(14;  16)(q32;q22-23), t(9;  14)(p13;q32), and t(6;  8)
(p10;q10) (Sawyer et al., 1998), t(14;  22)(q32;q11,12), t(11;  22)
(q13;q13), and der(7)t(7;  7)(p15,22;q22,32) (Sawyer et al., 
2001, 2005). Furthermore, the characterization of 100 pri-
mary MMs showed that the loss of 8p, found in 23% of the 
patients, may occur by multiple whole-arm translocations, 
thus indicating a new pathway for the loss of a specific chro-
mosome region in MM (Sawyer et al., 2001). The same au-
thors also reported on jumping segmental duplications in-
volving the chromosome region 1q12 ] q21 and adjacent 
bands (Sawyer et al., 2005). 
 In summary, the use of SKY substantially improves
the precision of karyotype analysis of malignant cells,
which in turn leads to a more accurate assessment of the 
genotypic abnormalities in those cells (Rowley et al., 
1999).
 Identification of recurrent translocations and 
breakpoints in mesenchymal tumors 
 Comparable to leukemias and lymphomas, mesenchy-
mal tumors have been characterized by chromosome trans-
locations leading to gene fusions. Importantly, the identifi-
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cation of specific rearrangements contributes to the differ-
ential diagnosis and subsequently helps for therapy 
stratifications of these tumors.
 For instance, benign fibro-osseous lesions of bone 
(BFOL) comprise a group of clinically distinct entities with 
significant histologic overlap and often occur in children 
and adolescents. Sixteen cases of BFOL including ossifying 
fibromas, osteofibrous dysplasias, and fibrous dysplasias re-
vealed clonal aberrations fusing breakpoints on chromo-
some bands Xq26 and 2q33, and carried multiple copies of 
chromosomes 8, 12, and/or 21 (Parham et al., 2004). 
 In case of lipoblastomas or infantile lipomas, a rare adi-
pose tumor occurring exclusively in childhood, a chromo-
somal rearrangement involving the long arm of chromo-
some 8 can assist in the differential diagnosis from myxoid 
or well differentiated liposarcoma. Preliminary data indi-
cated that the  PLAG1 gene on 8q12 is affected (Astrom et al., 
2000). Using SKY, complex aberrations were also resolved 
in lipoblastomas: 92,XXYY,t(7;  8)(p22;q11.2)x2[8]/46,XY
[16] and 46,XY,r(8),del(13)(q12),der(16)ins(16;  8)(q22;q24
q11.2)[cp13]/46,XY[7] confirming the involvement of chro-
mosome band 8q11.2 ] q12 (Chen et al., 2000). 
 Ewing’s sarcoma (ES) is an aggressive neoplasm which 
typically arises within the extremities or pelvis of a child or 
adolescent. The accurate and rapid diagnosis of ES is essen-
tial for clinical management. Since ES of the skull is rare, 
only accounting for approximately 6% of all cases, the con-
sistency of the translocations such as the common translo-
cation t(11;  22)(q24;q12) and the less frequent translocations 
t(21;  22), t(7;  22), t(17;  22) and t(2;  22) indicated the diagnostic 
value of molecular cytogenetic analysis (Carlotti et al., 
1999). Secondary chromosomal changes, e.g. chromosome 
numbers in excess of 50, may be associated with a poor 
prognosis for ES patients (Kullendorff et al., 1999) and may 
indicate tumors that are less responsive to treatment (Zie-
lenska et al., 2001). Shing et al. (2002) identified a novel, 
unbalanced translocation involving chromosomes 16 and 
17 in three of eight ESs leading to the loss of the long arm of 
chromosome 16 and the short arm of chromosome 17. Re-
current breakpoints were located at chromosome bands 
16p11.2, 16q11.1, 17p11.2 and 17q11.2. 
 Osteosarcomas (OSs) are often highly aneuploid. A total 
of 531 rearrangements were identified by SKY in 14 pri-
mary OS tumors and four OS cell lines, of which 300 break-
points were assigned to a specific chromosome band (Bay-
ani et al., 2003). 29% of the breakpoints were located in 
centromeric or pericentromeric regions leading to whole-
arm chromosome translocations. The highest frequency of 
alterations included the gain of chromosome bands 
8q23 ] q24 and 17p13 ] p11 and rearrangements of the 
long arm of chromosome 20. Specific sequences mapping 
to these chromosome regions will likely have a role in the 
development and progression of OS. A detailed character-
ization and quantification of the amplicons on the short 
arms of chromosomes 6 and 17 was carried out by FISH 
analysis, in addition to the detection of several novel recur-
rent breakpoint clusters and reciprocal translocations (Lau 
et al., 2004). 
 Proximal-type epithelioid sarcomas are characterized by 
an aggressive clinical course and rhabdoid morphology. 
They cause serious diagnostic dilemmas, being easily mis-
diagnosed as a variety of other malignant neoplasms. The 
identification of two cases with a similar translocation t(10; 
 22) suggested a role for one or more genes on chromosome 
22 in the pathogenesis of this tumor. A gain of the long arm 
of chromosome 8 including the  MYC  gene was also a fre-
quent event (Lualdi et al., 2004). 
 Rhabdomyosarcoma in children is a ‘small round blue 
cell tumor’ that displays skeletal muscle differentiation. A 
surprisingly high level of chromosomal changes was detect-
ed in rhabdomyosarcoma cell lines of embryonal and of al-
veolar origin (ERMS and ARMS) (Pandita et al., 1999), in-
cluding translocations involving chromosomes 1 and 15 
and chromosomes 2 and 15 (Roberts et al., 2001). Reciprocal 
translocations that generate the fusion gene  PAX3-FOXO1A 
 (t(2;  13))  or  PAX7-FOXO1A (t(1;  13))  were described in 
ARMS. Cell lines positive for these fusion genes were found 
to be highly complex with a wide range of chromosome 
numbers showing more than 50 chromosome rearrange-
ments, amplification of the hybrid genes, more than 20 
DNA changes detected by conventional CGH, and between 
8 and 21 gene copy changes seen by microarray CGH, also 
confirming the previously reported high-level amplifica-
tion of  MYCN  (Rodriguez-Perales et al., 2004).
 Gastrointestinal stromal (pacemaker cell) tumors (GIST/
GIPACTs) are known for activating KIT mutations and spe-
cific chromosome rearrangements. Cytogenetic and SKY 
analysis of 10 GIST/GIPACTs revealed clonal abnormalities 
in eight tumors, such as terminal deletions on chromosome 
arm 1p and losses of chromosomes 14 and/or 22. Thus, the 
role of chromosomal rearrangements in the pathogenesis of 
GIST/GIPACTs may be more complex than previously rec-
ognized (Andersson et al., 2002).
 The fusion of the nuclear receptor  TEC to various NH2-
terminal partners was found in extraskeletal myxoid chon-
drosarcomas (EMCs). Clonal chromosome abnormalities 
included a translocation t(9;  22)(q22;q12) (EWS-TEC) , vari-
ant translocations, such as t(9;  17)(q22;q11 ] q12), t(7;  9;17)
(q32;q22;q11), and t(9;  15)(q22;q21) and a deletion del(22)
(q12 ] q13). Additional abnormalities consisted of a gain of 
the long arm of chromosome 1 and trisomies of chromo-
somes 7, 8, 12, and 19 (Sjogren et al., 2003b). 
 Rare tumors have not been analyzed as intensely as com-
mon cancers. An unbalanced translocation between chro-
mosomes 1 and X and a trisomy 8 were detected in a pleu-
ropulmonary blastoma (PPB) (Barnard et al., 2000). This 
malignant intrathoracic pediatric tumor arises from the 
lung, pleura, or mediastinum. 
 In some instances tumor histogenesis still remains un-
clear today, for instance for alveolar soft-part sarcoma 
(ASPS). Using SKY, an unbalanced translocation der(17)
t(X;17)(p11.2;q25) was identified (Joyama et al., 1999). Re-
cently, molecular analysis determined the fusion product 
between  TFE3 (a transcription factor gene) at chromosome 
band Xp11 and a novel gene designated as  ASPSCR1 at chro-
mosome band 17q25. 
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 These findings also underline the importance of molec-
ular cytogenetic applications for the study of rare tumors 
paving the road for improved patient care based on indi-
vidual genotype-phenotype correlations.
 SKY analysis of sporadic and familial epithelial cancers 
 The next decennial task for scientists and physicians is 
to implement the combination of genetic profiling and gene 
expression analysis as the new gold standard into tumor di-
agnostics and prognostics in order to improve medical ser-
vice and to predict clinical courses for cancer patients. 
 Chromosome aberrations detected in squamous cell 
carcinomas 
 Squamous cell carcinomas of the head and neck
(HNSCC) arise through a multistep process of genetic al-
terations as a result of exposure to environmental agents 
such as tobacco smoke, alcoholic beverages, and viruses, in-
cluding human papillomavirus (HPV). 
 A striking feature of HNSCC is frequent breaks in cen-
tromeric regions resulting in whole arm translocations and 
isochromosome formation ( Fig. 3 ). In contrast to adenocar-
cinomas, HNSCCs showed that DNA sequences of both 
centromeres contributed to the formation of a fused centro-
mere (Hermsen et al., 2005). The karyotypes of oral squa-
mous cell carcinoma (OSCC) are near-triploid and contain 
multiple structural and numerical abnormalities (Reshmi 
et al., 2004). Cell lines derived from HNSCC and from
premalignant oral epithelium revealed amplifications at 
3q26 ] q27 in 42% of the cases (Singh et al., 2001). Losses of 
chromosomes 15 and 22 and gains of chromosomes 10 and 
20 correlated significantly with an unfavourable outcome in 
primary untreated HNSCCs (Bergamo et al., 2005). The 
comprehensive approach of CGH, SKY and expression 
analysis showed that several deregulated genes mapped to 
regions of genomic imbalance and chromosomal rearrange-
ments (Squire et al., 2002). An HPV16-infected cell line cul-
tured from a tongue-base SCC revealed multiple integrated 
viral DNA copies in blocks throughout the genome. Subse-
quent chromosome breakage studies suggested that the ob-
served viral-cellular integration sites may have occurred 
within common fragile sites (CFSs). Additional studies us-
ing RT-PCR for viral transcripts showed oncoprotein ex-
pression from episomal and integrated viral sequences (Ra-
gin et al., 2004). Akervall et al. (2004) studied cell lines de-
rived from HNSCC that were either cisplatin sensitive or 
resistant. Distinct differences in the genetic and expression 
profiles indicated that cisplatin resistance is multifactorial 
and that novel drug targets must be defined to improve tu-
mor response. 
 Angiosarcoma of the head and neck most commonly in-
volves the skin of the scalp or face; primary involvement of 
the sinonasal region is exceedingly rare. Complex chromo-
somal abnormalities with the presence of multiple hypodip-
loid clones, together with several near-triploid to near-tet-
raploid clones showing structural abnormalities of chromo-
 Fig. 3. Representative SKY karyotype of the HNSCC cell line scc078. Arrows indicate the whole chromosome arm 
translocations, reading from 1 to X: (1q;18p), (4p;12p), (5p;18p), (8q;10p), 2x (11q;Xq) and (11q;13q). Tissue-specific dif-
ferences of centromeric breakage between squamous cell carcinomas and adenocarcinomas were reported by Hermsen 
et al. (2005). Reprinted from Hermsen et al. (2005) with permission from Nature Publishing Group. 
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somes 1, 3, 4, 9, 14, 16, 17, 18, and 22 were described in a 
patient with sinonasal angiosarcoma complicated with 
marrow involvement (Wong et al., 2001).
 A balanced translocation t(3;  7)(p25;q34) and a dicentric 
chromosome translocation dic(15;  22)(p11;p11) were found 
as the only abnormalities in a patient with a minimally in-
vasive follicular thyroid carcinoma (FTC). This study rep-
resented the second case of FTC where 3p25 is involved in a 
balanced translocation supporting the existence of a gene 
locus in this region which may be involved in the tumori-
genesis of thyroid carcinomas (Lui et al., 2000).
 The molecular cytogenetic characterization and com-
parison of squamous cell carcinoma (SCC) and adenocarci-
noma (AC) as subtypes of non-small-cell lung cancer 
(NSCLC) indicated common and distinct genetic changes. 
Hierarchical clustering simulation depicted gains of chro-
mosomal regions 2p13 ] p11.2, 3q25 ] q29, 9q13 ] q34, 12p, 
12q12 ] q15 and 17q21, and loss of the short arm of chromo-
some 8 in preferential association with SCC pathogenesis. 
Recurring rearrangements involved translocations t(1;  13), 
t(1;  15), t(7;  8), t(8;  15), t(8;  9), t(2;  17) and t(15;  20) (Sy et al., 
2004b), aberrations characteristic for AC are shown below.
 Chromosome aberrations detected in adenocarcinomas 
 A comparison between squamous cell carcinomas and 
adenocarcinomas by analyzing chromosome aberrations 
using Array CGH, SKY and FISH analyses was performed 
by Hermsen et al. (2005). The identification of centromeric 
breaks associated with whole arm translocations in adeno-
carcinoma and squamous cell carcinoma cell lines revealed 
that whole arm translocations were more frequent in squa-
mous cell carcinomas (112 in nine cell lines and 9 in one 
short-term culture) than in adenocarcinomas (13 in seven 
cell lines) and most often resulted in copy number altera-
tions. Array CGH analysis demonstrated that in all squa-
mous cell carcinomas and in most adenocarcinomas the 
breakpoints of unbalanced whole arm translocations oc-
curred between the two clones flanking the centromeres. 
However, FISH with centromeric probes revealed that in 
squamous cell carcinomas the marker chromosomes with 
whole arm translocations contained centromeres comprised 
of material from both participating chromosomes, while in 
adenocarcinomas centromeric material from only one of 
the chromosomes was present. These observations support 
the hypothesis that different mechanisms of centromeric 
instability underlie the formation of chromosomal aberra-
tions in adenocarcinomas versus squamous cell carcinomas 
(Hermsen et al., 2005). Another comparison between SCC 
and AC was performed for NSCLC. Common events of 
gains of chromosome regions 1q21 ] q24, 5p15 ] p14, and 
8q22 ] q24.1, and loss of bands 17p13 ] p12 were seen in 
both groups. The gain of the long arm of chromosome 8 was 
a frequent finding. In contrast to the translocations t(7;  8), 
t(8;  15), and t(8;  9), the translocation t(8;  12)(q21 ] q22; 
q22 ] q24) was exclusively found in AC tumors (Sy et al., 
2004b). SKY analysis also uncovered chromosomal aberra-
tions in AC lung tumors obtained from women who were 
lifelong nonsmokers. A ploidy status of hypertetraploidy 
was found with recurring derivative translocations involv-
ing chromosome arms 3q, 8q, 12q, 15q, 22q, and Xq (Sy et 
al., 2004a).
 The diagnosis of a benign salivary basal cell adenoma 
was made of an unencapsulated, but well-demarcated, firm 
and lobular tumor removed from the lower and superficial 
part of the left parotid gland. G-banding and SKY-analysis 
revealed the karyotype 46,XX,der(7)t(7;  13)(p15;q32),der
(13)inv(13)(q12q32)t(7;  13)(p15;q32). The only common ab-
normality of the so far published cases is one or two extra 
copies of chromosome 8. It remains to be determined if the 
translocation t(7;  13) and/or inv(13) are recurrent in basal 
cell adenomas (Sjogren et al., 2003a). 
 Hepatocellular carcinomas (HCC) carry chromosome 
aneuploidy ranging from near-diploid to hyperhexaploid 
karyotypes. Chromosome regions 1p13 ] q21, 8p12 ] q21, 
17p11 ] q12, 17q22, and 19p10 ] q13.1 were involved in
multiple rearrangements. Predominantly pericentromeric 
breakpoints clustered in chromosome bands 2q33 ] q34, 
3p13 ] q12, 4p14 ] q12, 5p10 ] q11, 7p12 ] q11, 10q10 ] q11, 
11q10, 11q13 ] q21, 12q10 ] q13, 12q22 ] q23, 13q10 ] q14, 
15q10, 16q10 ] q13, 18p11 ] q11, 20p11 ] q13.1, 21q10, and 
22q10. Correlating the tumor size and the number of aber-
rations, a significantly higher number of structural changes 
was found in tumors larger than 4 cm. Rearrangements such 
as translocations t(1;  8), t(1;  11), t(1;  19), and t(17;  21) that were 
identified in both primary tumors and cell lines might rep-
resent markers that reflect proliferative advantages (Wong 
et al., 2000). Another set of HCC cell lines revealed the fol-
lowing recurrent translocations: t(X;11), t(1;  10), t(4;  16), 
i(5)(p10), t(7;  21), t(8;  17), t(9;  22), i(10)(p10), t(14;  20), t(16; 
 22), and t(17;  19). It was noteworthy that consistent chromo-
some 10 aberrations, in particular t(1;  10)(q10;p10), were de-
tected in all four cell lines and that microsatellite analysis 
indicated a common deleted region of 10q23 ] q26 (Pang et 
al., 2000, 2002). FISH mapping with BACs narrowed a 
breakpoint on chromosome 19 to the region of 19p13.12 ] 
p12. Expression analysis revealed the single downregulated 
gene  ACP5 (tartrate-resistant acid phosphatase type 5) on 
chromosome arm 19p (Chan et al., 2005). A gain of the long 
arm of chromosome 1 and rearrangements of chromosome 
1 involving pericentromeric breakpoints are consistent 
findings in human HCC. Hypomethylation of satellite 2 
(Sat2) DNA in 1q12 was found by Southern blotting using 
methyl-sensitive enzyme digestion in strong correlation 
with chromosome breakpoints in band 1q12 and gains of 
the long arm of chromosome 1 ( P  ! 0.001). Of particular 
interest was the finding of Sat2 DNA hypomethylation in 
several adjacent nontumorous liver tissues. Thus, Sat2 de-
methylation may contribute early on to the progression of 
liver carcinogenesis (Wong et al., 2003). Information on the 
clonal relationship between tumor nodules in patients diag-
nosed with HCC holds prognostic significance for the pre-
diction of recurrence and postoperative treatment. Wong et 
al. (2005) found tumor nodules in 83.3% of the analyzed 
cases to cluster concordantly. The development of drug re-
sistance either at the onset or during the course of treatment 
was linked to aberrations on chromosome 10 and position-
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al profiling suggested the candidate gene  ECHS1 (Hu et al., 
2004).
 To identify chromosomal translocations specific to gas-
tric cancer (GC), SKY analysis was performed on estab-
lished cell lines and cancerous ascitic fluids. Chromosome 
8 was the most frequently involved in rearrangements (65 
breaks), followed by chromosomes 11 (53), 1 (49), 7 (46), 13 
(37), 3 (36), 17 (33), and 20 (29). Frequent breakpoints were 
detected in chromosome bands 8q24.1 (30 breaks), 11q13 
(29), 13q14 (16), 20q11.2 (14), 7q32 (13), 17q11.2 (13), 18q21 
(12), 17q23 (9), 18q11.2 (9). SKY analysis identified a total of 
242 chromosomal rearrangements including 190 reciprocal 
and non-reciprocal translocations. The recurrent combina-
tions of chromosome bands involved in translocations were 
8q24.1 and 13q14 (3 cases), 8q24.1 and 11q13 (3), 11q13 and 
17q11.2 (2), and 18q11.2 and 20q11.2 (2). The  MYC and 
 CCND1 genes were found to be amplified forming homoge-
neously staining regions (HSRs) (Yamashita et al., 2005).
 Ghadimi et al. (2000) compared the cytogenetic profiles 
of mismatch-repair-deficient diploid versus mismatch-re-
pair-proficient aneuploid colorectal carcinoma cell lines. 
Aneuploid carcinomas revealed an average of 19 chromo-
somal imbalances per cell line and the occurrence of centro-
some amplifications. All diploid tumors contained normal 
centrosomes and only a few chromosome aberrations. Sim-
ilar studies were performed with comparable results (Ab-
del-Rahman et al., 2001; Melcher et al., 2002; Mohr and 
Illmer, 2005). Surprisingly, a near-diploid MMR-proficient 
cell line (HCA7) revealed multiple reciprocal translocations 
thus defining a third group of colorectal tumors (Abdel-
Rahman et al., 2001). The colon carcinoma cell lines SW480 
and SW620 were derived from different tumor stages of the 
same patient. Abnormalities found exclusively in SW620 
cells (gains of 5pter ] 5q11, 12q12 ] q23, 15p13 ] p11, and 
16q21 ] q24 and losses of 2pter ] p24, 4q28 ] qter, and 
6q25 ] qter) were viewed as changes that occurred in puta-
tive metastatic founder cells (Melcher et al., 2002). In con-
trast, a cell line established from a colon adenoma was found 
to be microsatellite stable and the SKY analysis revealed no 
chromosomal alterations. Nevertheless, incubation with 
butyrate resulted in a time- and dose-dependent inhibition 
of proliferation and in a significant increase in cellular dif-
ferentiation. Thus colon adenoma cell line GEKI-2 may pro-
vide a versatile tool for further exploring the underlying 
mechanisms of protective and promoting factors in early 
colon cancerogenesis (Menzel et al., 2004).
 Cell lines derived from pancreatic carcinomas were si-
multaneously studied by CGH and SKY analysis (Ghadimi 
et al., 1999). Recurring chromosomal gains were detected 
on chromosome arms 3q, 5p, 7p, 8q, 12p, and 20q. Chromo-
some losses were mapped to chromosome arms 8p, 9p, 17p, 
18q, 19p, and chromosome 21. Unbalanced translocations 
included most frequently i(5)(p10), del(11)(q23), i(12)(p10), 
i(1)(q10), del(7)(q22) and del(10)(p11) (Sirivatanauksorn et 
al., 2001). The comparison with CGH data from primary 
pancreatic tumors indicated that a specific pattern of chro-
mosomal copy number changes was maintained in cell cul-
ture. Copy number increases on chromosome 20q were
validated with a probe specific for the nuclear receptor co-
activator  NCOA3 that maps to chromosome 20q12 and cor-
related with increased expression (Ghadimi et al., 1999). 
Molecular events involved in pancreatic cancer also include 
mutations in the dominant oncogene  KRAS and the tumor 
suppressor genes  TP53 ,  CDKN2A and  SMAD4 (Sirivata-
nauksorn et al., 2001).
 Numerous genomic imbalances characteristic of stage 
IV clear cell renal cell carcinoma (CCRCC) were studied by 
analyzing ten cell lines established from primary renal tu-
mors. The mutational status of  VHL (3p25) and  MET (7q31), 
genes implicated in renal carcinogenesis, were determined 
for each case. All cases with  VHL inactivation had loss of 
chromosome arm 3p and gain of chromosome arm 5q re-
lated primarily to unbalanced translocations, no balanced 
translocations were noted. Gains of chromosome 7 were not 
associated with mutations of  MET . Specific chromosomal 
alterations that were previously related to a poor clinical 
outcome were also found in these lines derived from pa-
tients with metastatic disease: losses at 8p, 9p, and 14, and 
gains of 10 and 17 (Pavlovich et al., 2003). 
 Metaphase chromosomes obtained from 24 short-term 
cultured transitional cell bladder carcinomas and five blad-
der carcinoma cell lines showed specific chromosomal 
gains and losses, but no recurrent translocation. The appli-
cation of SKY and FISH techniques improved the karyo-
type descriptions by identifying 32 additional numerical 
changes, by establishing the chromosomal origin of 27 
markers and two ring chromosomes, by redefining 53 aber-
rations and by detecting 15 hidden chromosomal rear-
rangements. Early changes in superficial tumors were 
found to include regional losses of chromosomes 8, 9 and 
11 and gains of the long arms of chromosomes 1 and 18. 
More aggressive tumor phenotypes were characterized by 
losses of the short arms of chromosomes 4 and 17 and the 
formation of an isochromosome 5p (Fadl-Elmula et al., 
2001). A model for bladder cancer progression (cell lines 
T24 and T24T) was studied by SKY and CGH analysis and 
positional expression profiling (PEP) (Harding et al., 2002). 
Chromosomes 8, 12, and X showed similar results for all 
three methods, whereas a region on the long arm of chro-
mosome 10, gained in T24T compared with T24, was not 
associated with changes in gene expression. In addition, a 
candidate gene  (RhoGDI2)  that may be responsible for the 
invasive phenotype was identified on chromosome 12p 
(Harding et al., 2002).
 Numerous unbalanced translocations but also reciprocal 
translocations, isochromosomes and deletions were identi-
fied in cell lines and primary tumors derived from patients 
with high-grade serous adenocarcinoma of the ovary (Rao 
et al., 2002). Recurring breakpoint clusters were mapped at 
chromosomal bands 1p36, 2p11, 2p23, 3p21, 3q21, 4p11, 
6q11, 8p11, 9q34, 10p11, 11p11, 11q13, 12p13, 12q13, 17q21, 
18p11, 18q11, 20q11, and 21q22. Recurrent interstitial dele-
tions of chromosome bands 8p11, 11p11, and 12q13 and a 
recurrent unbalanced translocation der(6)t(6;  8)(q11;q11) 
were also detected. In addition, an HSR localized to chro-
mosome band 11q13 was found using SKY to be derived 
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from chromosome 12. Subsequent CGH studies revealed 
the origin of the amplified DNA sequences from chromo-
some region 12p11.2 (Rao et al., 2002). Furthermore, SKY 
analysis was applied to characterize cells derived from low 
and high passage numbers of an ovarian carcinoma cell line. 
Several specific aberrations were shared between the two 
cell lines whereas others were unique. Upon prolonged pas-
sage in tissue culture the cells developed resistance against 
flavopiridol, the first inhibitor of cyclin-dependent kinases 
to enter clinical trials. It is feasible that the observed genet-
ic changes underlie the acquisition of drug resistance (Bible 
et al., 2000).
 Breast cancer cell lines have been widely used as models 
in functional and therapeutical studies. Kytola et al. (2000) 
characterized 15 human breast carcinoma cell lines (BT-
474, BT-549, CAMA-1, DU4475, MCF7, MDA-MB-134, 
MDA-MB-157, MDA-MB-361, MDA-MB-436, MPE600, 
SK-BR-3, T-47D, UACC-812, UACC-893, and ZR-75-1) by 
CGH and SKY analysis. A multitude of mostly unbalanced 
structural and numerical chromosomal aberrations was 
identified with simple translocations, typically consisting 
of entire translocated chromosome arms, being the most 
common structural aberrations. Complex marker chromo-
somes included material from up to seven different chro-
mosomes. Translocations t(8;  11), t(12;  16), t(1;  16), and t(15; 
 17) were frequently found, although the resulting deriva-
tive chromosomes and their breakpoints were strikingly 
dissimilar (Kytola et al., 2000). There is still only limited 
knowledge on the order of appearance of different types of 
genetic aberrations in breast cancer. Rennstam et al. (2001) 
studied the  ERBB2 (Her-2/neu) and  CCND1 (cyclin D1) on-
cogene amplification in flow cytometrically sorted diploid 
and nondiploid tumor cell populations. The results indi-
cated that ploidy shift, i.e., aneuploidization, in breast can-
cer is a late genetic event, which is preceded by both onco-
gene amplifications as well as many chromosomal rear-
rangements.
 Cancer of the uterine cervix (CaCx) is often associated 
with infection of the patient with high-risk HPVs, however, 
additional genetic changes are required for tumor progres-
sion. Cottage et al. (2001) found a translocation of chromo-
some 10 or an isochromosome i(10q) in immortalised kera-
tinocytes and established CaCx cell lines suggesting that 
genes on chromosome 10 are important in HPV mediated 
immortalisation in vitro. Harris et al. (2003) studied widely 
used cervical cancer (CC) cell lines. Several recurrent struc-
tural chromosomal rearrangements, including der(5)t(5;  8)
(p13;q23) and i(5)(p10); deletions affecting chromosome 
bands 2q33 ] q36, 5p11, 5q11, and 11q23; and breakpoint 
clusters at 2q31, 3p10, 3q25, 5p13, 5q11, 7q11.2, 7q22, 8p11.2, 
8q11.2, 10p11.2, 11p11.2, 14q10, 15q10, 18q21, and 22q11.2 
were identified by SKY analysis. Further characterization of 
genes in the breakpoint clusters may provide clues for un-
derstanding the biology and clinical behavior of CC (Harris 
et al., 2003).
 Human prostate cancer cell lines, such as LNCaP, PC-3, 
DU145, 22Rv1, CWR-R1, DuCaP, LAPC-4, MDA PCa 1, 
MDA PCa 2a, MDA PCa 2b, PC-346C, PSK-1, and VCaP 
were studied by SKY (Pan et al., 1999; van Bokhoven et al, 
2003). Chromosome abnormalities were identified in all cell 
lines, although the number and complexity varied greatly 
among them. PC-346C, established from a primary tumor, 
exhibited only three clonal structural abnormalities, while 
DuCaP, established from a metastasis of a patient with a 
hormone-refractory tumor, exhibited a high number (31) 
and complex structural abnormalities. Breakpoints were 
identified in chromosomal regions (e.g., 1, 2, 4, 6, 8p, 10q, 
13q, 15, and 16q) that were previously described as being 
involved in prostate cancer.
 In solid tumors recurrent reciprocal translocations have 
only rarely been reported. Tumor heterogeneity and numer-
ous complex clonal and non-clonal aberrations per cell as 
well as difficulties in obtaining metaphase chromosomes 
from fresh tumor material have restricted the success of de-
fining tumor specific translocation breakpoints followed by 
gene identification. Nevertheless, copy number changes 
and breakpoint cluster of chromosome regions were corre-
lated with tumor stages and other clinical and biological 
findings and their identification in primary tumors using 
interphase cytogenetics will thus support prognostication. 
SKY analysis will always be helpful to determine structural 
aberrations and complement Array-CGH and expression 
studies to further the elucidation of the processes leading to 
tumorigenesis and tumor progression and to prepare for 
better therapeutic strategies.
 SKY analysis of neuroepithelial tumors  
 In addition to  MYCN amplification and chromosome 1 
short-arm deletions/translocations detected by convention-
al cytogenetics in neuroblastomas (NBLs), molecular cyto-
genetic studies of advanced-stage NBLs disclosed a high 
prevalence of gains of the long arm of chromosome 17 in the 
context of complex karyotypes (more than three changes 
per metaphase) including complex unbalanced rearrange-
ments. A strikingly high prevalence of the unbalanced 
translocation der(11)t(11;  17), leading to concomitant 11q 
loss and 17q gain, delineated a distinct cytogenetic group, 
not having 1p deletion and/or  MYCN amplification, but ad-
ditional changes in chromosomes 3 and 7q. In contrast, the 
17q translocations with partners other than 11q were associ-
ated with 1p deletion and/or  MYCN amplification (Stark et 
al., 2002). Chromosome aberrations of NBL were later on 
grouped into early (aberrations involving chromosomes X, 
1, 3 and 19) or late (involving chromosomes 9, 13, 15, 18, 20, 
and 21) karyotypic events. However, the gain of the long 
arm of chromosome 17 that was detected in 80% of the tu-
mors could not be related to the time of occurrence (Betts 
et al., 2005). NBL cell sublines resistant to vincristine (VCR) 
and doxorubicin (DOX) were established by Kotchetkov et 
al. (2003). The development of drug resistance and acquisi-
tion of certain karyotypic alterations is associated with an 
increase of additional malignant properties that may con-
tribute to the poor prognosis in advanced forms of NBL. 
 The molecular cytogenetic analysis of the neuroglioma 
cell line H4 (NBL) revealed a monoclonal and near triploid 
genotype with 24 structural aberrations. The generation of 
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transcription factors by fusion proteins might be the reason 
for impaired mRNA expression of the  LGI1  candidate tu-
mor-suppressor gene (Krex et al., 2001). In glioblastomas, 
Kubota et al. (2001) identified recurrent marker chromo-
somes, e.g. t(4;  16)(q21;q23), and amplifications of chromo-
somal bands such as 4q12, 16q13 and others. Interestingly, 
amplified segments were often found to be translocated or 
inserted, and low-level amplifications prevailed. 
 A so far unknown unbalanced translocation der(17)t(7; 
 17)(?;q?) was identified in uveal melanoma cell lines and pri-
mary uveal melanomas (Naus et al., 2001). Additionally, ab-
normalities involving chromosome 6 or 8 were found to be 
twice as common as observed with cytogenetic analysis. 
 Chromosome aberrations detected in familial tumors  
 Searching for genetic biomarkers in HNSCCs indicated 
that the loss of chromosomes 17 and 22 might be associated 
with a family history of cancer (Bergamo et al., 2005). 
 Looking for constitutional chromosome translocations 
in order to identify susceptibility genes in familial urothe-
lial cell carcinomas (UCC) Aben et al. (2001) performed 
routine chromosome banding and SKY analysis, however, 
no aberrations were detected.  
 Members of a Japanese family were found to be afflicted 
with late onset CCRCC (RCC, 4 patients), gastric cancer 
(one patient) and exocrine pancreatic cancer (one patient). 
A germline translocation t(1;  3)(q32;q13.3) was identified in 
five members of the family including all three RCC cases 
tested. Identification of the genes residing at the break-
points and  VHL mutations will help to explain the familial 
occurrence of these tumors (Kanayama et al., 2001). In an 
attempt to define the cytogenetic aberrations from early tu-
mors to late RCC, Phillips et al. (2001) studied 23 renal tu-
mors harvested from six unrelated VHL patients. Cysts and 
low-grade solid lesions were near-diploid and contained 1–2 
reciprocal translocations, dicentric chromosomes, and/or 
isochromosomes. In contrast, a high-grade lesion and its 
nodal metastasis were found to be aneuploid. These find-
ings also illustrated the cytogenetic heterogeneity of differ-
ent VHL lesions from the same kidney, supporting the mul-
ticlonal origins of hereditary RCCs (Phillips et al., 2001). 
 Studying mouse and rat tumor models with SKY  
 Rat and mouse have become important animal models 
to study human tumorigenesis, tumor progression and to 
perform functional investigations in vivo. The development 
of powerful cytogenetic tools such as SKY has allowed for 
routine karyotyping of mouse and rat chromosomes (Li-
yanage et al., 1996; Buwe et al., 2003). Several studies under-
lined that the improved ability to detect chromosome rear-
rangements using a combination of SKY, CGH and FISH 
analyses is helpful for a correct study design and detailed 
interpretation of the results. 
 Chromosome aberrations of human and mouse acute 
promyelocytic leukemia (APL) were compared by Le Beau 
et al. (2002). Expression of the human  Pml-Rara comple-
mentary DNA initiated the development of leukemia in mu-
rine granulocyte precursor cells. Recurring numerical ab-
normalities included the gain of chromosome 15 in the 
mouse tumors, which is comparable to the gain of chromo-
some 8 in human. Thus, these results suggested that  Pml-
Rara –initiated murine leukemias are associated with a de-
fined spectrum of genetic changes, and that these secondary 
mutations recapitulate, in part, the cytogenetic abnormali-
ties found in human APL (Le Beau et al., 2002). The coex-
pression of a reciprocal form of the fusion,  Rara-Pml , in-
creased the likelihood of APL development (55–60%), but 
did not shorten latency. The spleen tumor cells from trans-
genic mice with APL were also studied for evidence of sec-
ondary genetic events using SKY analysis. Interstitial or ter-
minal deletions of the distal region of one copy of chromo-
some 2 (del(2)) were found in one of five tumors expressing 
 Pml-Rara , but in 11 of 13 tumors expressing both  Pml-Rara 
and  Rara-Pml  ( P  ! 0.05). These cells contained additional 
chromosome changes such as gain of chromosome 15 or 
losses of chromosomes 11, X or Y or were found to be tetra-
ploid, which may provide an advantage to the transformed 
cells (Zimonjic et al., 2000). Furthermore, different cooper-
ating events may generate leukemia via different activated 
cytokine signaling pathways (Le Beau et al., 2003), such as 
Flt3, Csf2rb1/2 and Il3. Also involved is the increased  Myc 
expression via ras/Mapk activation, Bclxl expression via 
 Stat5 (signal transducer and activator of transcription 5) 
and Pik3/Akt1 (phosphatidylinositol 3-kinase/v-akt mu-
rine thymoma viral oncogene homolog), and Bcl2 phos-
phorylation via Mapk1/3 (extracellular signal-related ki-
nase 1/2) or PLC  (phospholipase C-  ). Identifying the 
genes that drive chromosome gains or losses in human and 
murine myeloid leukemias may offer insights into the patho-
genesis or progression of leukemias and may provide new 
therapeutic targets (Le Beau et al., 2003).
 To study the v-abl/myc-dependent tumorigenesis in 
mouse B cells, BALB/c PreB lymphocytes were immortal-
ized by v-abl and stably transfected with a conditional
MycER vector. A comprehensive analysis using chromo-
some painting, SKY, FISH and mBANDing revealed a du-
plication of the E1/E2 bands of chromosome 11. These find-
ings suggest that the Pre-B ABL/MYC cells may be used to 
analyze the genetic changes affecting chromosome 11 that 
are associated with v-abl/myc-dependent tumorigenesis in 
mouse B cells (Benedek et al., 2004). 
 A mouse model of malignant plasma cell tumor (PCT) 
development was characterized by the SKY analysis of in-
duced primary BALB/c plasmacytomas for the presence of 
chromosomal aberrations that took place subsequent to 
the initiating Myc-activating translocations T(12F1;  15D2) 
or T(6C1;  15D2). Recurrent amplifications of chromosome 
1 and promiscuous non-reciprocal translocations of chro-
mosome 5 (52% prevalence) suggested the existence of im-
portant PCT progressor genes on bands 1B/C and 5F (Cole-
man et al., 2000). Similar translocations involving chro-
mosome band 5F were detected by Helmrich et al. (2005) 
in an E  -myc lymphoma model with defects of the  Cdkn2a 
(alias INK4a/ARF) locus. Furthermore, SKY and CGH 
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analysis allowed for predicting responsiveness to antican-
cer therapy based on molecular findings at diagnosis. The 
gain of chromosome 14, which was never detected in 
INK4a/ARFnull lymphomas, defined an ARFnull sub-
group with superior treatment outcome. Gain of chromo-
some 6 was identified as a recurrent chromosomal aberra-
tion that predisposed ARFnull tumors to their subsequent 
INK4a loss during therapy ( Fig. 4 ). These data illustrated 
how cytogenetic information from cancer specimens might 
complement established prognostic markers and may im-
prove anticancer treatment strategies (Helmrich et al., 
2005). 
 The DCPC21 plasmacytoma belongs to a small group of 
plasmacytomas that are unusual in that they appear to be 
translocation-negative. DCPC21 harbors  Myc and  Igh genes 
on extrachromosomal elements (EEs) from which  Myc is 
transcribed, as shown by  Myc mRNA tracks and extrachro-
mosomal gene transfer experiments. The transcriptional 
activity of these EEs is further supported by the presence of 
the transcription-associated phosphorylation of histone H3 
(H3P) on the EEs. Thus, Myc expression is achieved by an 
alternative mechanism outside the chromosomal locations 
of the  Myc gene. Therefore, other ‘translocation-negative’ 
experimental and human tumors with fusion transcripts or 
oncogenic activation may indeed carry translocation(s), 
however, in an extrachromosomal form (Wiener et al., 
1999).
 Tumors which arose from hyperplastic ductal and lobu-
lar mammary lesions in a transgenic mouse model express-
ing the Myc gene under the MMTV  8 LTR promoter 
 Fig. 4. Cytogenetic characteristics of  ARF null and  INK4a/ARF null lymphomas in a  E  -myc transgenic mouse mod-
el. ( A ) Representative SKY data of a primary  ARF null (A10) lymphoma sample. ( B ) Summarized cytogenetic results based 
on SKY and CGH analyses (green bars to the right and red bars to the left indicating gains and losses, respectively) of 
 ARF null (n = 15),  INK4a/ARF null (n = 17) and ctrl. lymphomas (n = 6). Note that no chromosome 14 gain has been de-
tected in  INK4a/ARF null samples, although this alteration is common in  ARF null and ctrl. lymphomas (Helmrich et 
al., 2005). Reprinted from Helmrich et al. (2005) with permission from Nature Publishing Group. 
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showed high rates of apoptosis and of chromosomal insta-
bility. Normal Trp53 was strongly expressed in premalig-
nant mammary glands and in mammary tumors derived 
from the MMTV-Myc strain. When the MMTV-Myc strain 
was mated to a Trp53-deficient strain, a lack of both  Trp53 
alleles in the presence of  Myc overexpression resulted in a 
dramatic hyerplastic alteration in mammary gland devel-
opment. In contrast, only mild ductal and lobular hyperpla-
sias were seen in MMTV-Myc mice that contained both 
Trp53 alleles (MMTV- Myc/Trp53 +/+); an intermediate phe-
notype occurred in mice with a single intact (MMTV- Myc/
Trp53 +/–)  Trp53 allele. A detailed chromosomal analysis of 
the developing mammary carcinomas using SKY revealed 
that there were multiple chromosomal alterations in the 
 Myc -overexpressing cells that contained either one or two 
unmutated  Trp53 alleles. Variable ploidy changes, a com-
mon translocation of chromosome 11, and other chromo-
somal aberrations were observed. These data thus support 
an interaction between Myc and Trp53 in mammary devel-
opment, but suggest that loss of Trp53 is required neither 
for  Myc -dependent tumorigenesis nor for  Myc -dependent 
chromosomal instability. The comparison of the patterns of 
chromosomal aberrations with human breast cancers 
showed similarities in several syntenic regions (McCor-
mack et al., 1998; Weaver et al., 1999).
 Germline mutations of the  Brca1 gene are responsible for 
most cases of familial breast and ovarian cancers, but so-
matic mutations are rarely detected in sporadic events. The 
fact that  Brca1 is responsible for the integrity of the genome 
was demonstrated by Shen et al. (1998). Murine embryos 
carrying a  Brca1 null mutation were found to be develop-
mentally retarded and hypersensitive to   -irradiation, sug-
gesting a failure in DNA damage repair. This notion was 
supported by SKY analysis of metaphase chromosomes, 
which displayed numerical and structural aberrations. Ex-
cision of exon 11 of  Brca1 in the mouse, using a conditional 
knockout (Cre-loxP) approach, resulted in mammary tu-
mor formation after long latency. All tumors exhibited 
chromosome instability, yet they displayed a pattern of 
chromosomal gain and loss that was similar to the pattern 
in human breast carcinomas. The distal region of chromo-
some 11, which is syntenic to human chromosome 17q11 ] 
qter, the mapping position of  ERBB2 was found to be gained. 
The proximal region of chromosome 11 (11A-B), which is 
orthologous to the short arm of human chromosome 17 was 
lost. Based on additional information the authors concluded 
that the pattern of genomic imbalances is conserved be-
tween BRCA1-associated mammary gland tumors in mice 
and humans (Weaver et al., 2002). 
 The conditional expression of the activated  Erbb2 gene 
under its endogenous promoter in the mammary epitheli-
um of the mouse resulted in accelerated lobular develop-
ment and focal mammary tumors. Short-term cultures of 
primary tumors revealed the amplification of the  Erbb2 
gene in correlation with a loss on mouse chromosome 4 in-
volving bands D–E, a region that is orthologous to distal 
human chromosome 1p. This region may harbour putative 
tumor suppressor genes that are of importance for the tu-
mor formation in this model of human breast cancer (Mon-
tagna et al., 2002). Another breast cancer model based on 
the expression of polyomavirus middle T antigen under the 
control of the mouse mammary tumor virus promoter in 
transgenic mice showed the induction of aggressive mam-
mary gland adenocarcinomas at an early age. A combined 
chromosome analysis and gene expression study revealed a 
consistently increased expression of septin 9  (Sept9) . The 
family of septin genes is involved in a plethora of cellular 
processes, including cytokinesis in yeast and vesicle trans-
port, and possesses GTPase activity. These results suggested 
that signaling via members of the septin family plays a nov-
el and common role in breast tumorigenesis (Montagna et 
al., 2003). 
 Annexin 7  (ANXA7) acts as a tumor suppressor gene in 
prostate cancer, where loss of heterozygosity and reduction 
of ANXA7 protein expression is associated with aggressive 
metastatic tumors. Srivastava et al. (2003) developed an 
 Anxa7  +/–  knockout mouse that showed a cancer-prone phe-
notype. Genome array analysis of HCC tissue indicated that 
the  Anxa7  +/–  genotype was accompanied by profound re-
ductions of expression of several other tumor suppressor 
genes, DNA repair genes, and apoptosis-related genes. The 
authors concluded that haploinsufficiency of  Anxa7 expres-
sion appears to drive disease progression to cancer because 
of genomic instability through a discrete signaling pathway 
involving other tumor suppressor genes, DNA repair genes, 
and apoptosis-related genes (Srivastava et al., 2003). DMINs 
and HSRs are cytological manifestations of DNA amplifica-
tion and were not previously found in mouse HCCs and 
adult human HCCs. Zimonjic et al. (2001) identified DMINs 
derived from mouse chromosome 19. The recognition of 
these loci could lead to the cloning of new genes or identifi-
cation of known genes important in development or pro-
gression of HCC.
 Early passage mouse cell lines of lung adenocarcinomas 
were studied using the SKY technology by Sargent et al. 
(2002). Gains and losses of entire chromosomes and recur-
rent translocations were identified. The minimal regions of 
chromosomal alteration, 1G1, 2F1, 4C4, 6D, 7F1, 8B3, and 
12C2, contain putative susceptibility genes for mouse lung 
adenocarcinoma. Similar linkage groups are altered in hu-
man lung adenocarcinoma, implying that this mouse is a 
valid genetic model for the study of human lung adenocar-
cinoma susceptibility (Sargent et al., 2002). Novel candidate 
genes for the progression of lung cancer related to systemic 
metastases and to a poor prognosis were identified by ana-
lyzing parental and modified NCI-H460 cells (H460SM) af-
ter endobronchial implantation into a nude rat (Liu et al., 
2004). SKY detected a new inversion within 17q and loss of 
an extra normal copy of chromosome 14 present in parental 
NCI-H460 cells. Expression profiling of orthotopic primary 
tumors revealed the differential expression of 360 genes 
(Liu et al., 2004). 
 The widely used azoxymethane (AOM)-induced mouse 
colon tumor model recapitulates many of the histopatho-
logical features associated with the multistage progression 
of human sporadic colorectal cancers (CRCs). CGH, SKY 
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and microsatellite analysis of a cell line derived from these 
carcinogen-induced tumors revealed a pseudotetraploid 
karyotype with loss of only the Y chromosome, thereby pro-
viding evidence for the minimal role of CIN. Most primary 
tumors displayed low-level microsatellite instability (MSI-
L) and showed a significant expansion to high-level instabil-
ity (MSI-H) in the AJ02-NM0 cells. Based on their molecu-
lar and cytogenetic findings, the authors proposed that car-
cinogen-induced tumors may develop via mechanisms 
independent of the ‘classical’ CIN or MSI pathways (Guda 
et al., 2004).
 Investigations of cell lines established from skin tumors 
of mice expressing either the E6 or E7 oncoprotein of the 
HPV type 16 under control of the keratin 14 promoter 
showed that tumorigenesis via E6 requires copy number in-
creases of mouse chromosome 6, which is partially ortholo-
gous to human chromosome 3q, a region gained in HPV- 
associated carcinomas (Schaeffer et al., 2004). Pons et al. 
(2005) studied mouse epidermal carcinogenesis by analyz-
ing a minor epithelial cell subpopulation (CarC-R) con-
tained in the highly malignant spindle carcinoma cell line 
CarC. Furthermore, several single-cell clones with either 
stable epithelial or fibroblastic phenotypes were isolated 
from an explanted CarC-R tumor (CarC-RT). A T(14;  15) 
translocation was present in only a minority (1.9%) of CarC-
R cells, but was widely spread in CarC-RT and its derived 
cell clones, regardless of their epithelial or fibroblastic phe-
notype. These results indicated that the T(14;  15) segregated 
with malignancy (Pons et al., 2005).
 Rehen et al. (2001) presented direct evidence for genom-
ic variability, manifested as chromosomal aneuploidy, 
among developing and mature neurons in the brain of the 
normal mouse. The analysis of embryonic cerebral cortical 
neuroblasts in situ revealed lagging chromosomes during 
mitosis, suggesting the normal generation of aneuploidy in 
these somatic cells. SKY analysis identified approximately 
33% of neuroblasts as aneuploid, showing either hyperploi-
dy, monosomy, and/or trisomy. Interphase fluorescence in 
situ hybridization supported this rate of aneuploidy and
detected aneuploidy also in adult neurons (Rehen et al., 
2001). 
 Surprisingly, the study of tumor-associated endothelial 
cells identified chromosome aberrations and aneuploidy us-
ing SKY analysis as well as centrosome anomalies in two 
independent xenograft mouse models. There was no evi-
dence of human tumor-derived chromosomal material in 
the mouse tumor endothelial cells (Hida et al., 2004).
 An in vivo model system for metastatic prostate cancer 
was developed by Wang et al. (2005). Pieces of prostate can-
cer tissue from a patient were grafted in testosterone-sup-
plemented male NOD-SCID mice at the subrenal capsule 
graft site permitting high tumor take rates. Subsequently, 
the tumor tissues were grafted into mouse prostates. Sam-
ples of metastatic tissue were regrafted in mouse anterior 
prostates. SKY analysis showed few chromosomal altera-
tions in the PCa1-met subline. Thus, orthotopic xenografts 
of the transplantable tumor lines and metastatic sublines 
could be used for studying various aspects of metastatic 
prostate cancer, including metastasis to bone (Wang et al., 
2005). 
 Research on meiotic chromosome segregation was per-
formed on mouse oocytes (Hodges et al., 2002). Mutations 
that affect oocyte growth were found to increase the fre-
quency of congression failure at first meiotic metaphase. A 
cause-and-effect relationship was suggested because the in-
creased congression failure was correlated with meiotic 
non-disjunction. These results implicated that it may be 
possible to develop prophylactic treatments for reducing the 
risk of age-related aneuploidy (Hodges et al., 2002). Fur-
thermore, a mouse sertoli cell line was characterized by 
SKY, because it provides an ideal system for the in vitro 
analysis of function and responsiveness to biochemical/
hormonal factors (Guttenbach et al., 2001).
 Studying mechanisms of tumorigenesis 
 Mouse models and human and mouse cell lines are fre-
quently used to study not only a specific disease but also 
gene pathways and gene functions. 
 The diverse group of cancer cell lines established by the 
National Cancer Institute for the purpose of anticancer 
drug discovery was analyzed using SKY analysis (Roschke 
et al., 2003). Along with the karyotypic description of the 
cell lines the authors defined and studied karyotypic com-
plexity and heterogeneity (metaphase-to-metaphase varia-
tions) based on three separate components of genomic anat-
omy: (a) ploidy, (b) numerical changes, and (c) structural 
rearrangements. A striking lability of centromeric regions 
distinguished the epithelial tumor cell lines. Balanced 
translocations were as frequent in absolute number within 
the cell lines derived from solid as from hematopoietic tu-
mors. Important similarities were noticed between karyo-
type changes in cancer cell lines and those seen in primary 
tumors. This dataset offers insights into the causes and con-
sequences of the destabilizing events and chromosomal in-
stability that may occur during tumor development and 
progression. It also provides a foundation for investigating 
associations between structural genome anatomy and can-
cer molecular markers and targets, gene expression, gene 
dosage, and resistance or sensitivity to tens of thousands of 
molecular compounds (Roschke et al., 2003).
 The function of the  MYC gene as part of the DNA repair 
mechanisms was reported for the first time by Karlsson et 
al. (2003). The overexpression of  MYC  disrupted the repair 
of double-strand DNA breaks, resulting in a several-magni-
tude increase in chromosomal breaks and translocations.
 Telomeres are known to play crucial roles in protecting 
the integrity of eukaryotic chromosomes and maintaining 
genomic stability of human cells. Telomere lengths of indi-
vidual chromosomes in normal human somatic cells are 
heterogeneous and undergo progressive shortening during 
aging. When applying SKY analysis and sequential telomere 
quantitative fluorescence in situ hybridization on meta-
phases obtained from ovarian and esophageal epithelial 
cells, Deng et al. (2004) detected a correlation between the 
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distribution of critically short telomeres and the occurrence 
of specific chromosomal structural aberrations. Hao and 
Greider (2004) established mouse embryonic fibroblast 
(MEF) lines from late generation mTR –/–  and wild-type an-
imals. In early passages, mTR –/–  G6 cell lines showed more 
chromosome ends with no telomere signal, more chromo-
some end-to-end fusions and greater radiosensitivity than 
wild-type lines. At later passages wild-type MEF lines re-
vealed a similar or higher rate of genomic instability than 
mTR –/–  cells. Both post-crisis mTR –/–  G6 MEFs and wild-
type MEFs showed loss of Trp53 and   -H2afx phosphoryla-
tion in response to irradiation, indicating a loss of DNA 
damage checkpoints (Hao and Greider, 2004). Qi et al. 
(2005) described a new mechanism by which short telo-
meres inhibit tumorigenesis through interference with on-
cogenic translocations. They proposed that telomere fusion 
to DNA double strand breaks competes with the generation 
of oncogenic translocations and thus reduces tumor forma-
tion. The conclusion was drawn based on studies in mice 
that are null for both ataxiatelangiectasia-mutated  (Atm) 
and telomerase RNA  (mTR) . The first generation (G1)
Atm–/– mTR–/– mice showed a lower rate of tumor formation 
than Atm–/–  mTR  +/+  mice. Translocations of the T-cell re-
ceptors on chromosome 14, which initiate tumorigenesis, 
were interrupted by fusion with telomeres and telomere re-
peats were also detected at the translocation junctions in 
pre-malignant thymocytes (Qi et al., 2005). Reversal of telo-
mere shortening by the forced expression of telomerase in 
normal cells has been shown to elongate telomeres and ex-
tend the replicative life span. Extension of the life span as a 
consequence of the functional inactivation of Trp53 is
frequently associated with loss of genomic stability. Analy-
sis of telomerase induced extended-life-span fibroblast
(TIELF) cells by G-banding and SKY detected the transient 
formation of aberrant structures, which were subsequently 
resolved in higher passages. However, the Trp53-dependent 
G1 checkpoint was intact as assessed by functional activa-
tion of Trp53 protein in response to ionizing radiation and 
subsequent Trp53-mediated induction of p21Waf1/Cip1/
Sdi1. TIELF cells were not tumorigenic and had a normal 
DNA strand break rejoining activity and normal radiosen-
sitivity in response to ionizing radiation (Pan et al., 1999; 
Vaziri et al., 1999).
 DNA repair mechanisms after DNA double-strand 
breaks are very intriguing and general processes in life. 
Xrcc2 is a protein with homology to Rad51, the core com-
ponent of homologous recombination (HR), and with a 
non-redundant role in damage repair. High levels of chro-
mosomal alterations and reduced SCE-rates were found in 
primary or immortal  Xrcc2  –/–  embryonic fibroblasts by 
Deans et al. (2003), which may be comparable to the disrup-
tion of breast cancer-predisposing  (Brca) genes. Several 
components of the nonhomologous DNA endjoining 
(NHEJ) pathway in the maintenance of genomic stability in 
mouse embryonic fibroblasts (MEFs) were assessed by Fer-
guson et al. (2000). MEFs homozygous for mutations that 
inactivate either DNA ligase IV (Lig4) or Ku70 displayed 
dramatic genomic instability. The aberrant events ranged 
from chromosomal fragmentation to nonreciprocal com-
plex translocations. The authors concluded that NEHJ plays 
a crucial role as a caretaker of the mammalian genome, and 
that an alternative repair pathway exists that often leads to 
nonreciprocal translocations (Ferguson et al., 2000).
 Poly(ADP-ribose) polymerase (PARP)-1, a detector of 
single-strand breaks, plays a key role in the cellular response 
to DNA damage. It was suggested that Parp1-deficient mice 
have a severe telomeric dysfunction leading to telomere 
shortening and increased end-to-end fusions. Using Q-
FISH and SKY analyses Samper et al. (2001) showed that 
primary Parp1 –/–  cells showed a frequency of only two end-
to-end fusions per 100 metaphases, much lower than that 
described previously. 
 The extent of chromosome instability induced in cul-
tured human colon carcinoma HCT116 cells by the antitu-
mor radiomimetic enediyne antibiotic C-1027 was exam-
ined using SKY (McHugh et al., 2005). Chromosome mis-
rejoining was associated to a much greater extent with 
C-1027–induced than with ionizing radiation–induced cell 
growth inhibition. The extreme cytotoxicity of C-1027 may 
reflect both induction and erroneous repair of DNA double-
strand breaks in the whole genome and/or in subgenomic 
targets such as telomere sequences. 
 Radiation-induced neoplastic transformation of human 
epithelial cells was studied by cytogenetic analysis of the 
human thyroid epithelial cell line HTori-3. The exposure of 
the cell line to different doses of   - and   -irradiation led to 
subsequent tumor formation in athymic nude mice. Chro-
mosome abnormalities were determined in the parental line 
HTori-3 and in nine different HTori lines established from 
the developed tumors. Several chromosomal aberrations 
were found to be characteristic for simian virus 40 immor-
talization and/or radiation-induced transformation of hu-
man thyroid epithelial cells. In contrast, deletions on chro-
mosomes 9q32 ] q34 and 7q21 ] q31 as well as increased 
copy numbers of chromosome 20 were identified as cytoge-
netic markers important for the tumorigenic process (Zit-
zelsberger et al., 2001). 
 Antisense and ribozyme-mediated temporary inhibition 
of  BUB1  was used  to study the consequences of mitotic 
checkpoint failure on the development of aneuploidy. The 
analysis of cell colonies selected by soft agar growth showed 
evidence of chromosome instability and delayed senes-
cence, without being tumorigenic in nude mice. These data 
suggested that chromosomal instability and aneuploidy are 
early changes that precede tumorigenicity in the multistep 
process leading to neoplastic transformation (Musio et al., 
2003).
 Mapping of artifical transgene insertion sites in mouse 
chromosomes was facilitated by the sequential application 
of SKY and FISH analysis as demonstrated by Matsui et al. 
(2002). A renin/green fluorescent protein (GFP) fusion gene 
construct (Ren-GFP) was found to be integrated in the 
transgenic mouse, Tg(Ren-GFP)1Kwg, into a single chro-
mosomal site of chromosome 4 at A2–3. Generating trans-
genic mouse models using large transgenes led to the obser-
vation that more than 40 copies of a specific transgene 
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 (bEMS4) were stably incorporated in a single insertion site 
at the breakpoint of a BAC-mediated chromosome translo-
cation T(3;  9) (Abrahams et al., 2003). Hardt et al. (1999) 
developed an in situ technique to label individual euchro-
matic chromosome arms in interspecific crosses between 
 Mus musculus (MMU) and  M. spretus (MSP). Comparative 
hybridization of MMU versus MSP DNA and subsequent 
spectral analysis of the euchromatic hybridization profiles 
discriminated between maternal (MMU) and paternal 
(MSP) chromosomes in F1 hybrids. This allowed for the vi-
sualization of recombination events in back crosses of the 
two mouse species and, thus, could be used as an adjunct 
technique in genetic mapping studies (Hardt et al., 1999).
 Another goal of the development of mouse models is the 
implementation and testing of cancer gene therapy. Trans-
fer and expression of suicide genes is considered as a proac-
tive tool to enhance the safety of somatic transgenesis. Frank 
et al. (2004) used retroviral vectors encoding the thymidine 
kinase gene of herpes simplex virus and transduced EL-4 
lymphoma cells. The induced experimental tumors in con-
geneic C57Bl/6 mice were treated with ganciclovir (GCV) 
resulting in tumor remission. GCV-resistant relapses oc-
curred and were found to be associated with either epigen-
etic transgene silencing, escape by postinsertional recombi-
nation or the complete loss of the retrovirally marked fusion 
chromosome, which was confirmed by SKY analysis. Con-
sidering the mechanisms of escape, the proactive use of sui-
cide genes to prevent complications of insertional mutagen-
esis may still be efficient (Frank et al., 2004). In addition, 
leukemic complications in mice after highcopy retroviral 
gene transfer of the multidrug resistance 1  (Abcb1) cDNA 
were reported. SKY demonstrated additional chromosomal 
translocations in a subset of cases, indicative of secondary 
genetic instability. Also, insertional mutants may be ampli-
fied in vitro prior to transplantation. On the basis of these 
findings, the authors suggested the use of preclinical dose-
escalation studies to define a therapeutic index for retrovi-
ral transgene delivery (Modlich et al., 2005). 
 A large amount of T cells is required for adoptive immu-
notherapy in a clinical setting. Therefore, T-cell lifespan ex-
tension by human telomerase reverse transcriptase (hTERT) 
transduction is of particular interest, but constitutive ex-
pression of hTERT is associated with malignant transfor-
mation. Schreurs et al. (2005) performed an extensive cyto-
genetic analysis of hTERT transduced MART-1 (melanoma 
antigen recognized by T cell 1) – and human papillomavirus 
type 16 (HPV16) E7–specific human CD8 +  cytotoxic T lym-
phocytes (CTLs). The results showed the development of 
minor chromosomal aberrations in an hTERT-transduced 
MART-1–specific CTL clone, whereas severe clonal aberra-
tions were detected in an hTERT-transduced HPV16 E7–
specific CTL clone. Furthermore, hTERT transduction did 
not protect CTLs from immunosenescence, because the 
HPV16 E7–specific, hTERT-transduced CTL clone showed 
a decreased functional activity on prolonged culture. There-
fore, the currently available data suggest that clinical appli-
cation of hTERT-transduced CTLs should proceed with 
caution (Schreurs et al., 2005). 
 Analyzing chromosome evolution 
 Comparative mapping data between the Hominidae and 
Cercopithecidae genomes were supplemented by a study of 
baboon  (Papio hamadryas) metaphase chromosomes using 
probes derived from human chromosomes. Human (HSA) 
chromosome 2 was found to be homologous to baboon 
(PHA) chromosomes 12 (HSA2q) and 13 (HSA2p), whereas 
three baboon chromosomes corresponded to two different 
human chromosomes: PHA3 to HSA7 and HSA21, PHA7 
to HSA14 and HSA15, and PHA10 to HSA20 and HSA22 
(Best et al., 1998). 
 The baboon and macaque karyotypes appeared to be 
similar by G-banding studies and SKY analysis. In addition, 
a SKY karyotype was established from a rheboon, the only 
long-term survivor of 26 pregnancies resulting from mat-
ings between female baboons  (Papio hamadryas) and male 
rhesus macaques  (Macaca mulatta) . No differences were
detected in any of the rheboon’s pairs of autosomes, rein-
forcing the apparent identity of the two parental karyo-
types. Nevertheless, a testicular biopsy revealed hypoplasia 
of the seminiferous tubules with few Leydig cells and large 
lumena. Thus, the testicular and meiotic findings in the
rheboon were similar to those observed in other hybrids, 
even though the parental karyotypes appear identical 
(Moore et al., 1999).
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